Lars Ekman Insider Trading $RARE Ultragenyx Pharmaceutical Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Lars Ekman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Lars Ekman. Lars Ekman is in AMARIN CORP PLC\UK ($AMRN) and Director in AMARIN CORP PLC\UK ($AMRN) and Director in INTERMUNE INC ($ITMN) and in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Prothena Corp plc ($PRTA) and Director in SOPHIRIS BIO INC. ($SPHS) and Director in Spark Therapeutics, Inc. ($ONCE).
Lars Ekman in Ultragenyx Pharmaceutical Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Lars Ekman: Director
Holdings: 14,445 shares
Current Value: $1,053,185
Latest Transaction: Jun 28 2021
$RARE Market Capitalization: $2.92B
$RARE Previous Close: $72.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Lars Ekman in Ultragenyx Pharmaceutical Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMRN, ITMN, PRTA, SPHS, ONCE, RARE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 28 2021 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Director | Option Exercise | A | 93.20 | 4,125 | 384,450 | 4,125 | |
| Jun 28 2021 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Director | Grant | A | 0.00 | 2,145 | 0 | 14,445 | 12.3 K to 14.4 K (+17.44 %) |
| Jun 30 2020 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Director | Option Exercise | A | 76.58 | 4,250 | 325,465 | 4,250 | |
| Jun 30 2020 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Director | Grant | A | 0.00 | 2,550 | 0 | 12,300 | 9.8 K to 12.3 K (+26.15 %) |
| Jun 13 2019 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Director | Option Exercise | A | 58.74 | 5,000 | 293,700 | 5,000 | |
| Jun 13 2019 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Director | Grant | A | 0.00 | 3,000 | 0 | 9,750 | 6.8 K to 9.8 K (+44.44 %) |
| Jun 20 2018 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Director | Option Exercise | A | 80.69 | 5,000 | 403,450 | 5,000 | |
| Jun 20 2018 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Director | Grant | A | 0.00 | 3,000 | 0 | 6,750 | 3.8 K to 6.8 K (+80.00 %) |
| Jun 22 2017 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Director | Option Exercise | A | 65.66 | 3,750 | 246,225 | 3,750 | |
| Jun 22 2017 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Director | Grant | A | 0.00 | 1,875 | 0 | 3,750 | 1.9 K to 3.8 K (+100.00 %) |
| Jun 14 2016 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Option Exercise | A | 65.85 | 3,750 | 246,938 | 3,750 | ||
| Jun 14 2016 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Grant | A | 0.00 | 1,875 | 0 | 1,875 | 0 to 1.9 K | |
| Mar 21 2016 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Option Exercise | A | 54.28 | 15,000 | 814,200 | 15,000 |
Page: 1